RESULTS: Of 19 patients, 9 (47,4%) died and 10 (52,6%) surviving. The level of LBP serum decreased after 72 hours in surviving-sepsis patients, and increased in nonsurviving sepsis patients with significant different levels at 72 hours examination (P<0.05). The level of soluble-ICAM-1 which was high in the first admission showed in non-surviving sepsis patients, but the difference levels was not significant between surviving and non-surviving patients (P>0.05). In all patients were found high level of PCT serum since the first admission examination, decreasing levels were occurred significantly i n surviving patients after 72 hours (P<0.05) where high PCT levels were found in non-surviving patients after 72 hours. The median level of plasma protein C activity was low at the first admission especially in non-surviving sepsis patients, the decreasing level w as not significantly different after 72 hours (P>0.05) both in surviving and non-surviving patients.
CONCLUSIONS:
Increasing level of LBP and PCT in sepsis patients showed that those biomarkers useful for predict the clinical outcome in sepsis patients. Decreasing protein C activity level was not a good predictor in worsening clinical outcomes. Soluble ICAM-1 level was not a good marker for predict risk of sepsis severity. LBP and PCT tests were more useful in serially testing from the first admission of sepsis patients, those tests are more faster than bacterial culture. (2, 3, 4, 5) . TNF-, and IL-6 induced liver to release acute phase protein s erum a myloid A (SAA), C-reactive p rotein (CRP) and Procalcitonin (PCT). Sekresi PCT secretion is earlier and much more than SAA dan CRP secretion (6) . The half life of TNF-which 17 minutes is difficult to be detected in the first sepsis progression (3). Furthermore IL-6 has low sensitivity and specificity in adults sepsis patients (2 (10) . With this protocol the central venous oxygen saturation (ScvO2), mean arterial pressure (MAP), central venous oxygen saturation dan hematokrit w as m aintained for increasing haemodynamic parameter (Oxygenous supply in SIRS or sepsis patients).
SIRS/SEPSIS
Blood sample were collected at the first admission and after 72 hours for LBP, ICAM-1, PCT and protein C activity testing and for blood culture at the first admission. Other laboratory testing was used for monitoring the r esult o f treatment. Blood culture result was used for directing apropriate antimicrobial therapy.
Uncontrollable secretion o f proinflammatory cytokines rapidly in abnormal high levels could obtained pathological condition. This pathological effect caused by endothelial activation which release adhesion molecules such as E-selectin, ICAM-1, etc (7) and plasminogen activator inhibitor-1 (PAI-1) (8) . PAI-1 is strong inhibitor to tissue plasminogen activator which may lyse fibrin clot. In this condition activated Protein C induced fibrinolisis and inhibit trombosis a s an inflammatory r esponse (9) . U ltimately over reactive r esponse t o infection obtained endovascular endothelial damage, microvascular thrombosis, organ ischemic, multiorgan dysfunction and death (4) .
We investigate patients w ho have SIRS or sepsis criteria. The t reatment o f patients used Early Goal-Directed Therapy (EGDT) p rotocol guidelines (10) . Blood draw was performed serially at the first admission and after 72 hours treatment for LBP, ICAM-1, PCT and protein C activity testing, furthermore blood culture also performed at the the first admission, and other examination for monitoring patient s condition.
Materials & Methods
The study protocol was approved by Faculty of Medicine Hasanuddin University Ethics Committee. Written informed c onsent w as obtained f rom each subject.
LABORATORY EXAMINATION Blood s amples w ere collected into t he p lain t ube for LBP, ICAM-1 and P CT examination, b lood w as centrifuged t o obtained t he s era, p rotein C a ctivity sample was collected from plasma citrate. The samples were performed in Prodia Clinical Laboratory, Jakarta. Hematology t esting with E DTA-blood s ample was performed in Cinical Pathology Department, Wahidin Sudirohusodo H ospital, M akassar. LBP s erum w as performed i n Immulite System (chemiluminescent immunometric assay, DPC, USA). ICAM-1 serum was performed with Elisa method (R&D Systems, USA). PCT serum was performed with immunochromatography method (the rapid assay platform, BRAHMS, Germany) in semiquantitative results with 30 minutes incubation time. P rotein C a ctivity p lasma was performed w ith chromogenic substrate method. Protein C in patient's sample was activated by specific venom activator.
STATISTICAL ANALYSIS A 2-sided P value of <0,05 was considered significant for evaluating mean and median differences between the first admission groups and after 72 hours groups, using SPSS for window version 11.5.
BASELINE CHARACTERISTICS Baseline characteristics of subjects are shown in tablel 1. The subjects are post surgery patients who have clinical sign of SIRS and risk of sepsis. (table 2) , whereas there were significantly different mean level after 72 hours (p=0,042).
ICAM-1 SERUM LEVELS AND RISK OF CLINICAL OUTCOME
The median o f ICAM-1 levels decreased not significantly (p>0,05) in surviving and non-surviving patients (Table 3 .), and no significantly different at first and 72 hours levels between surviving patients and non-surviving patients (p>0,05). There were increasing means of ICAM-1 levels after 72 hours in surviving patients while its decreased in non-surviving patients ( PROTEIN C ACTIVITY PLASMA LEVELS AND RISK OF CLINICAL OUTCOME There were no significantly different levels of protein C activity at first and 72 hours (Table 2. and Table 3 .). But the decreasing of protein C activity means levels were showed in non-surviving patients after 72 hours (Fig.3.) . The means levels of protein C activity at the first admission were lower in non-surviving patients than surviving patients.
Discussion
Serum LBP level was higher in non-surviving sepsis patients than in surviving patients with good clinical outcome (12), while Opal et al also did not find any such correlation, but they reported significantly lower serum LBP levels in nonsurvivors than in survivors within 24 hours of onset of sepsis. They hypothesized that synthesis of LBP fails in the presence of rapidly progressive septic shock (13) . In surveillance study from hundreds patients has done by Carroll et al showed m any diseases or condition which may increase serum LBP levels such as sepsis, meningococcemia, .
Increasing s erum L BP levels (>46ug/ml) found in sepsis patients with suspected gram negative infections and related to high mortality number, showed a strong relationship between serum LBP level and severity of disease (12) . Severity of disease may be occured in conjunction with increased endotoxin in the systemic circulation. Endotoxemia may originate from regional hypoperfusion and mucosal ischemia, and promote translocation of endotoxin to the systemic circulation (14) . In this s tudy we did not perform endotoxin examination. Blood culture were performed at the first patient's admission into the ICU, bacterial identification was not known until this study was reported and so we are unable to assess its correlation with serum LBP levels. Suspected infection status was reported from clinical signs before received the culture results.
LBP testing a t t he first admission w as not significantly d ifferent between survivors and nonsurvivors, showed t hat initial L BP t esting i s not effective for predict clinical outcome of sepsis, it was suggested that all sepsis patients have synthesized LBP progressively since initial systemic infection occured. Whereas serum LBP levels decreased after 72 hours in survivors and increased in non-survivors, the difference serum LBP levels were also significant in survivors and non-survivors after 72 hours examination (p = 0,014, table 2). Serum LBP levels after 72 hours had positive correlation with patient's clinical outcome (r = 0,560, Kendall's tau test), showed that serum LBP levels more useful in serial testing for predict clinical outcome of sepsis.
Significantly decreasing s erum PCT levels in severe sepsis or septic shock patients who may have good clinical outcome is consistent with Harbarth's report (15) . Serum PCT levels significantly increased after 2-6 hours after LPS/endotoxin injection and maintaining a plateau through 8 and 24 h (16), showed in this study with a positive correlation between LBP and PCT at the first admission examination (r = 0,551, Kendall's tau test). PCT was induced in the liver by proinflammatory cytokine IL-6 (6). PCT testing with rapid platform assay i s more useful, shorter t urn around time compare to blood culture. This testing is effective for early prediction of sepsis clinical outcome, and may be used in conjuction with antimicrobial therapy. Antimicrobial t herapy has i mportant influence on serum PCT levels (15) so the dynamic levels of serum PCT in antimicrobial therapy may be useful for monitoring the effectivity of treatment. Serum PCT levels after 72 hours have positive correlation with clinical outcome of sepsis (r = 0,521, Kendall's tau tes). It showed that initial examination is not useful to predict the clinical outcome, it was needed serial examination to found the risk progression of sepsis.
Serum ICAM-1 levels were high in all patients and was not significantly changed after 72 hours ( table 2 and  table 3) , it was suggested in this study the endothelial dysfunction was occurred both in surviving or nonsurviving sepsis patients, t his adhesion m olecule was induced in activated endothelial cells and the become dysfunction (7). This s tudy also showed positive correlation between serum LBP levels and serum ICAM-1 levels at the first admission (r = 0,630, Spearman's r ho test), suggested t hat endothelial dysfunction was induced b y LPS/endotoxin. In non-survivors m ultiple o rgan failure have been occurred due to endothelial damage, serum ICAM-1 levels slight decreased in this patients. However the dynamic levels of ICAM-1 in this study did not show a significantly different (p>0.05) between survivors and non-survivors. So ICAM-1 testing was not suggested for predicting clinical outcome of sepsis patients.
Systemic inflammatory process and sepsis impair the endogenous fibrinolytic potential by inflammatory cytokines s o may diffuse endovascular injury, microvascular t hrombosis, m ultiorgan dysfunction, and death. The conversion of protein C to protein C activity may be impaired during sepsis as a result of down-regulation of thrombomodulin from endothelial cell by inflammatory cytokines (8) . In our study was showed from negative correlation between protein C activity and ICAM-1 (r = -0.76 with Spearman's rho) which may suggested endothelial dysfunction with high serum ICAM-1 level correlated with low plasma protein C activity level. The low level of plasma protein C activity found i n sepsis patients and increasing risk of death (17, 18, 19, 20) . This study could not give a good evidence for protein C activity testing as a predictor marker for clinical outcome from the first admission into the ICU or for monitoring in serial testing.
It w as difficult t o differentiate the etiological sepsis or systemic inflammatory cases from infection or from other sources due to the lack of specificity for identifying systemic inflammatory. C-reactive protein (CRP) has been used for predicting sepsis patient (21, 22) . In this years several markers have developed as sepsis markers such as LBP and procalcitonin (23, 24) . Inflammation w as associated w ith endothelial activation which expressed adhesion m olecule (7). Proinflammatory cytokines TNF-, IL-1 ) and IL-6 are capable of activating coagulation and inhibiting fibrinolysis, w hile p rocoagulant t hrombin m ay stimulate multiple inflammatory pathways.
Of 10 survivors, 6 patients have been surviving from severe sepsis and have recovered, in this patients serum PCT levels were > 10 ng/ml and serum LBP levels were high (177 -205 ug/ml) and after recovered the level of serum LBP decreased in the range 104 -158 ug/ml consistent with decreasing serum PCT levels (<10 ng/ml).
Serum LBP, PCT and ICAM-1 levels of sepsis patients i n this study increased. W hereas plasma protein C activity levels decreased, especially in .
This showed that LPS binding protein (LBP) induced systemic inflammatory and its progression to sepsis, and associated t o positive c orealtion between serum LBP levels and serum PCT levels. Systemic inflammatory and sepsis then activate endothelial dysfunction which were associated w ith positive correlation between s erum L BP levels and s erum ICAM-1 levels. Endothelial dysfunction may promote hypercoagulation which were related to the low level of plasma protein C activity in sepsis patients with high level of serum ICAM-1.
In summary, The initial levels of serum LBP and serum PCT could not used for predicting sepsis clinical outcome. Increasing serum LBP and PCT levels in severe sepsis patients who shock and death showed that these m arkers were useful for predicting the clinical outcome in sepsis patients when performed in serial testing. LBP testing may performed within 1 hour and PCT testing within 30 minutes. Those testing are more effective than blood culture which need 3 days incubation time. High levels of serum ICAM-1 at the first admission or in serial testing could not suggested for predicting the risk of sepsis because its levels did not change significantly, neither for plasma Protein C activity.
